Gong Chen
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Basic principles for astrocyte-to-neuron conversion.
Journal: Neural regeneration research
Published: April 05, 2026
A NeuroD1 AAV-Based Gene Therapy for Functional Brain Repair in Alzheimer's Disease-Like Non-Human Primate Model.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 13, 2025
Attenuating AAV-triggered innate immunity in the adult mouse nervous system via cGAS-STING pathway inhibition.
Journal: Acta pharmaceutica Sinica. B
Published: August 31, 2025
NeuroD1 gene therapy converts reactive astrocytes to functional new neurons in a mouse model of Alzheimer's disease.
Journal: Neural regeneration research
Published: May 23, 2025
NeuroD1 gene therapy inhibits glioma growth and extends life span through in vivo reprogramming approach.
Journal: Molecular therapy. Oncology
Published: May 14, 2025
Olig2 acts as an inducible barrier to in vivo astrocyte-to-neuron conversion.
Journal: Nature communications
Published: January 14, 2025
Transcription Factor-Based Gene Therapy Enables Functional Repair of Rat Following Chronic Ischemic Stroke.
Journal: CNS neuroscience & therapeutics
Published: January 07, 2025
In vivo neuroregenerative gene therapy to treat neurodegenerative disorders.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: September 30, 2024
NeuroD1-based in situ neural regeneration for the treatment of radiation-induced brain injury.
Journal: Neural regeneration research
Published: September 11, 2024
Glucose restriction induces degeneration of neurons with mitochondrial DNA depletion by altering ER-mitochondria calcium transfer.
Journal: Molecular psychiatry
Published: August 03, 2024
Last Updated: 09/26/2026